Search

Search Constraints

You searched for: Author/Creator Dientsmann, Rodrigo

Search Results

1. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018)

2. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018)

3. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer. (May 2021)